Yaping Liu (@yapingliu) profile picture

Assistant Professor in epigenomics and liquid biopsy, Northwestern University-Feinberg School of Medicine. Husband and a father of two kids.

Chicago, IL
Joined April 2010
Photo by Yaping Liu (@yapingliu)Photo by Yaping Liu (@yapingliu)Photo by Yaping Liu (@yapingliu)
MIT published a brutally honest report on what AI is doing to students. A committee of professors and students spent five months studying how AI changed learning on campus, and the findings read like a warning to every university on the planet. Study groups are disappearing. Office hours are emptying out. Problem sets and take-home exams no longer prove anything, because AI can produce credible solutions to almost any written assignment in the undergraduate curriculum. Students who lean on chatbots lose mastery and confidence, and some slip into what the report calls cognitive surrender, reaching for AI at the first hint of struggle. The numbers are rough. 46 percent of surveyed MIT undergrads use LLMs daily. 90 percent worry about their own overreliance. Undergrads who feel AI makes them replaceable now outnumber those who feel it makes them capable. The committee's answer surprised me. They refused to fight AI with surveillance. The report calls AI detectors unreliable, says lockdown browsers feel like spying, and warns that policing students builds a classroom atmosphere of mutual distrust. Instead, MIT wants to rebuild education around the things AI can't replace. That means oral exams, semester portfolios, in-person project work, and a required social component in every subject. The report even floats the idea of rethinking grades entirely, since without a GPA to optimize, much of the incentive to cheat with AI evaporates. The committee warns professors against replacing undergrad research assistants with AI agents just because they're cheaper, because a university exists to grow people, not output. The most famous tech school on earth admitted the machines broke its way of teaching. Its answer is more humans, not more software.
481
8,104
1,089
24,780
3,466,616
This is legitimately terrible for OpenAI --- but also Anthropic --- and it relates to their work in drug discovery. I read this as: prompts will be monitored and potentially acted on if we think there’s something scientifically and/or commercially valuable being disclosed. Now, the big problem for Anthropic is that they are increasingly seen to be competing with their customers. Outside of SF, many people also think of OpenAI/ChatGPT and Anthropic/Claude as somewhat interchangeable companies and products --- aka, if OpenAI do something, surely Anthropic will do it too? As so much IP relates to drug targets and people disclose these to Claude, I think we will see a lot of pharma companies stop using these tools or put up a lot of internal guardrails.
wtf is this way to handle mathematicians work and scientific communication TLDR: Leven and Tristan worked over several months on one of the Millenium Prize Problems with various AIs to reach final interesting results. OpenAI apparently heard about it in the last days and prompted their latest models to work on the direction Leven and Tristan found fruitful. They then tried to push for controlling communication of the result and dropping Leven from authorship with some very bad taste social pressure. Hope this is not a glimpse of the future we’ll get in science research with these dominating players playing marketing games hurtful for the real scientific community.
72
289
64
2,239
406,383
OpenAI (& Anthropic) really need to release very clear legally binding statements ASAP that this kind of behavior is against their official policy. If not, it is going to be a legal disaster for science. Even more reason to favor open source models not controlled by companies.
This is legitimately terrible for OpenAI --- but also Anthropic --- and it relates to their work in drug discovery. I read this as: prompts will be monitored and potentially acted on if we think there’s something scientifically and/or commercially valuable being disclosed. Now, the big problem for Anthropic is that they are increasingly seen to be competing with their customers. Outside of SF, many people also think of OpenAI/ChatGPT and Anthropic/Claude as somewhat interchangeable companies and products --- aka, if OpenAI do something, surely Anthropic will do it too? As so much IP relates to drug targets and people disclose these to Claude, I think we will see a lot of pharma companies stop using these tools or put up a lot of internal guardrails.
20
43
5
449
40,806
Molecular co-accessibility identifies coordinated regulation between distant cis-regulatory elements dlvr.it/TVKZzv
13
66
6,836
A @NorthwesternMed study suggests that a simple #BloodTest could help identify which patients with #HeadAndNeckCancer will be most likely to benefit from @immunotherapy, according to a study published in @jclinicalinvest. The advancement could help spare patients from ineffective treatment, said Yaping Liu, PhD (@yapingliu), assistant professor of #Biochemistry and #MolecularGenetics, who was senior author of the study. Read here: news.feinberg.northwestern.e…
3
7
860
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer: doi.org/10.1172/JCI196284
1
3
3
841
Behind the scenes: Cell-free DNA extraction by research associate Hailu Fu and computational analysis of cfDNA fragmentation led by first author Ravi Bandaru, a medical student.
2
5
680
Congratulations to my colleague Dr. Yapig Liu @yapingliu for developing rMDS a cfDNA fragmentomics biomarker from whole-genome sequencing data that can predict response to perioperative pembrolizumab. This method outperformed PD-L1, tumor fraction, and other fragmentomic metrics and identified patients with improved disease-free survival. #HNSCC #LiquidBiopsy #CancerResearch @NU_BMG_SQE @NUFeinbergMed @NorthwesternU @jclinicalinvest news.feinberg.northwestern.e…
8
15
1,604
A new @NorthwesternMed study suggests that a simple blood test could help identify which patients with head and neck cancer will be most likely to benefit from #immunotherapy, according to a study published in @jclininvest. The advancement could help spare patients from ineffective treatment, said Yaping Liu, PhD (@yapingliu), who was senior author of the study. Read more: news.feinberg.northwestern.e…
1
4
5
346
Our paper is out at JCI jci.org/articles/view/196284. We found that the variations of cell-free DNA end motif entropy across genomic regions predict immunotherapy response in head and neck cancer. Great collaboration with @TMWiseDraper. Congrats to @kyunkiwhynot
2
3
1
12
1,244
Yaping Liu retweeted
Replying to @medrxivpreprint
@medrxivpreprint Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer @UCincyMedicine @CincyResearch @NorthwesternU @TMWiseDraper @Hildy46 @yapingliu
2
1
324
Yaping Liu retweeted
New NIH Highlighted Topic: Technology Development for Genomics grants.nih.gov/funding/find-…
14
76
7,105
Join us today for the BMG Seminar Speaker Dr. Viktor Adalsteinsson! Hosted by Dr. Yaping Liu @yapingliu #epigenetics #TumorDNA #DNA @NUFeinbergMed @NorthwesternMed @broadinstitute
1
2
251
Yaping Liu retweeted
PlotGDP: an AI Agent for Bioinformatics Plotting researchhub.com/paper/110751…
2
166
3
907
62,355
Yaping Liu retweeted
Federal funding for US biomedical research is moribund. Since October 1 2025, NIH is -80% in new grants and -70% in values (total dollars). Labs are closing down and researchers are leaving science. To what end?
39
334
49
722
182,276
Yaping Liu retweeted
NIH is not issuing awards. You may think that it's because they it is coming up with new directions of research...The apposite is true. Here is a graph showing how many fewer new funding opportunities that NIH has posted over time. -91%, a trend that started on Jan 2025.
27
185
26
496
103,163
Our paper on deep single-cell DNA methylation analysis is out in Nature Communications rdcu.be/evfJm. Super elegant work by Nathan Spix describing replication dynamics, X-inactivation, and cell lineage identification.
4
9
29
1,333